203 related articles for article (PubMed ID: 30146180)
21. Revival of transcatheter PFO closure: A meta-analysis of randomized controlled trials - impact of shunt size and age.
Reinthaler M; Ozga AK; Sinning D; Curio J; Al-Hindwan HS; Bäckemo Johansson J; Jung F; Lendlein A; Rauch G; Landmesser U
Am Heart J; 2018 Jul; 201():95-102. PubMed ID: 29910060
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials.
Hakeem A; Marmagkiolis K; Hacioglu Y; Uretsky BF; Gundogdu B; Leesar M; Bailey SR; Cilingiroglu M
Cardiovasc Revasc Med; 2013; 14(6):349-55. PubMed ID: 24080379
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.
Zhang XL; Kang LN; Wang L; Xu B
BMC Cardiovasc Disord; 2018 Mar; 18(1):45. PubMed ID: 29499641
[TBL] [Abstract][Full Text] [Related]
24. Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment.
Melkumova E; Thaler DE
Interv Cardiol Clin; 2017 Oct; 6(4):487-493. PubMed ID: 28886840
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
Kwong JS; Lam YY; Yu CM
Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
[TBL] [Abstract][Full Text] [Related]
26. Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
Price MJ
Interv Cardiol Clin; 2017 Oct; 6(4):555-567. PubMed ID: 28886846
[TBL] [Abstract][Full Text] [Related]
27. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
Vidale S; Russo F; Campana C; Agostoni E
Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
[TBL] [Abstract][Full Text] [Related]
28. [Patent foramen ovale can cause cryptogenic stroke. Transcatheter closure as an alternative to medical therapy must be evaluated more].
Ladenvall P; Dellborg M
Lakartidningen; 2013 Sep 4-10; 110(36):1524-5. PubMed ID: 24163903
[No Abstract] [Full Text] [Related]
29. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
[TBL] [Abstract][Full Text] [Related]
30. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
Udell JA; Opotowsky AR; Khairy P; Silversides CK; Gladstone DJ; O'Gara PT; Landzberg MJ
Can J Cardiol; 2014 Oct; 30(10):1216-24. PubMed ID: 25154803
[TBL] [Abstract][Full Text] [Related]
31. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
[TBL] [Abstract][Full Text] [Related]
32. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
[TBL] [Abstract][Full Text] [Related]
33. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
[TBL] [Abstract][Full Text] [Related]
34. Ischaemic stroke with patent foramen ovale.
Jusufovic M; Thomassen L; Skjelland M
Tidsskr Nor Laegeforen; 2014 Jan; 134(2):180-4. PubMed ID: 24477152
[TBL] [Abstract][Full Text] [Related]
35. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.
Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR
Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325
[TBL] [Abstract][Full Text] [Related]
36. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler.
van de Wyngaert F; Kefer J; Hermans C; Ovaert C; Pasquet A; Beguin C; Sindic C; Sluysmans T
Arch Cardiovasc Dis; 2008; 101(7-8):435-41. PubMed ID: 18848685
[TBL] [Abstract][Full Text] [Related]
37. Patent Foramen Ovale: Stroke and Device Closure.
Suradi HS; Hijazi ZM
Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
[TBL] [Abstract][Full Text] [Related]
38. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
Dalen JE; Alpert JS
Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
[TBL] [Abstract][Full Text] [Related]
39. Transcatheter closure of patent foramen ovale does not reduce the risk of recurrent ischemic stroke versus medical therapy alone: a meta-analysis of randomized controlled trials.
Zhang B; Zhou J; Li H; Zhou M; Chen A; Zhao Q
Int J Cardiol; 2013 Nov; 169(6):e106-8. PubMed ID: 24383119
[No Abstract] [Full Text] [Related]
40. Patent foramen ovale and cryptogenic stroke: the hole story.
Furlan AJ; Jauss M
Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
